Capital World Investors
KRON

Capital World Investors’s Kronos Bio KRON Stock Holding History

Capital World Investors’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,080,633
Closed -$22.3M – 576
2022
Q1 		$22.3M Sell
3,080,633
-70,781
-2% -$604K ﹤0.01% 489
2021
Q4 		$42.8M Hold
3,151,414
– – 0.01% 458
2021
Q3 		$66.1M Hold
3,151,414
– – 0.01% 412
2021
Q2 		$75.5M Buy
3,151,414
+1,164,874
+59% +$29.5M 0.01% 406
2021
Q1 		$58.1M Buy
+1,986,540
New +$58.2M 0.01% 419

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Capital World Investors's KRON Position: Q2 2022 in Review

Capital World Investors sold out of Kronos Bio (KRON) in Q2 2022, closing a stake of 3,080,633 shares — an estimated $22.3M sold.

Capital World Investors first reported a position in KRON in Q1 2021 and held it in 5 quarters. The position peaked at $75.5M in Q2 2021. 93 funds tracked by Wall St. Rank hold KRON as of Q2 2022.

  • Capital World Investors reported no remaining Kronos Bio position as of Q2 2022 after selling out during the quarter.
  • Capital World Investors sold 3,080,633 Kronos Bio shares in Q2 2022, an estimated $22.3M.
  • Capital World Investors first reported a position in Kronos Bio in Q1 2021 and held it in 5 quarters.
  • Capital World Investors's Kronos Bio position peaked at $75.5M in Q2 2021.
  • 93 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2022.

Based on Capital World Investors's 13F filing for Q2 2022, filed 15 Aug 2022.